Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Luis Cordova-Bahena

Has grant

Researcher

National Autonomous University of Mexico

No Info

Research Interests

Explore related searches

Professors in Pharmaceutical Chemistry

Recent Grants

Grant: Close

Reposicionamiento de fármacos con capacidad de promover la homodimerización de PD-L1 en inmunoterapia contra cáncer (Drug repurposing in cancer immunotherapy: stabilizers of PD-L1 homodimers.)

Open Date: 2022-07-01

Close Date: 2024-11-01

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (4)

Marco A. Velasco-Velázquez

Professor

National Autonomous University of Mexico

View details

Nohemí Salinas-Jazmín

Profesora de Carrera Titular "B" definitiva

National Autonomous University of Mexico

View details

Zhiqiang An

The University of Texas Health Science Center at Houston

UNITED STATES

View details

Jose L Medina-Franco

Professor

National Autonomous University of Mexico

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luis Cordova-Bahena

Research Interests

Explore related searches

Recent Grants

Articles (11)

Daclatasvir, A Symmetric Drug for an Anti-Symmetric Target

Pseudouridine synthase 7 as a context-specific therapeutic target in cancer

Uso de supercómputo para el descubrimiento de fármacos: un caso de estudio sobre CK1ε

In silico-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers

Identification of New CD36 Antagonists by Structure‐Based Virtual Screening

In Silico Identification of 2,4-Diaminopyrimidine-Based Compounds as Potential CK1ε Inhibitors

<i>In silico</i> characterization of the interaction of AKR1B1 with the deacetylase activation domain (DAD)

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 Mpro Inhibitors from Large Chemical Libraries

Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning

Identification of a SARS-CoV-2 Mpro inhibitor from large chemical libraries using a consensus pharmacophore

Collaborators (4)

Marco A. Velasco-Velázquez

Nohemí Salinas-Jazmín

Zhiqiang An

Jose L Medina-Franco

Make your next move.